6-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 1g

4-(3,4-dichlorophenyl)-1H-imidazol-2-amine, 100mg

(5aS,10bR)-2-(2,4,6-Triisopropylphenyl)-5a,10b-dihydro-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate, 97%, 100mg

1H,1'H-2,2'-Biimidazole, 95.0%, 10g

(Z)-2-(benzo[d]thiazol-2-yl)-3-(2-chloro-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)acrylonitrile, 97%, 100mg

2-(4-ETHYLPHENYL)-2-METHYLPROPANOIC ACID, 95.0%, 500g

4-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 5g

4-Nitropyridine-N-oxide, 95.0%, 5g

1,2,3,4-Tetrahydro-4-oxonaphthalene-2-carboxylic acid, 97%, 5g

4-(1H-Benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine, 95.0%, 10g

Électrode combinée pH série LE LE409

4-Bromo-1-ethyl-1H-pyrazole-5-carboxylic acid, 95.0%, 250mg

2-Bromo-3-chlorophenol, 95.0%, 1g